|
THAP6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71818115290989E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.18123346846278E-13 |
| Normal-vs-Stage2 |
2.70810041058667E-11 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.68509650677606E-12 |
| Stage1-vs-Stage2 |
8.706200E-01 |
| Stage1-vs-Stage3 |
3.108500E-02 |
| Stage1-vs-Stage4 |
1.546490E-02 |
| Stage2-vs-Stage3 |
2.157200E-01 |
| Stage2-vs-Stage4 |
9.115800E-02 |
| Stage3-vs-Stage4 |
5.478800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.52970994047064E-14 |
| Normal-vs-AfricanAmerican |
1.77480000029817E-07 |
| Normal-vs-Asian |
1.07119979553261E-10 |
| Caucasian-vs-AfricanAmerican |
8.098200E-01 |
| Caucasian-vs-Asian |
2.552800E-01 |
| AfricanAmerican-vs-Asian |
5.948400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.15303338993544E-14 |
| Normal-vs-Female |
1.91069382537989E-13 |
| Male-vs-Female |
3.287000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.88689080921267E-13 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(81-100Yrs) |
1.99012999999582E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.484400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.239400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.765600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.989600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.301600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.140600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.011370E-04 |
| Classical-VS-Follicular |
1.245550E-01 |
| Classical-VS-Other |
7.552800E-01 |
| Classical-VS-Normal |
1.7483792191797E-12 |
| Tall-VS-Follicular |
1.84262999999296E-05 |
| Tall-VS-Other |
1.100590E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
4.517000E-01 |
| Follicular-VS-Normal |
1.04649955368075E-10 |
| Other-VS-Normal |
7.352300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.27662333429635E-12 |
| Normal-vs-N1 |
2.55300225404653E-11 |
| N0-vs-N1 |
4.572600E-01 |
|
|
